Opportunities and challenges for human papillomavirus vaccination in cancer

Viral Infections, Non-HIV

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Vaccine.

Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D

doi: 10.1016/j.vaccine.2019.12.017.

Viral Infections, Non-HIV

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial

Vaccine.

Leung TF, Liu AP, Lim FS, Thollot F, Oh HML, Lee BW, Rombo L, Tan NC, Rouzier R, De Simoni S, Suryakiran P, Hezareh M, Thomas F, Folschweiller N, Struyf F

HIV / AIDSViral Infections, Non-HIV

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis

Lancet Infect Dis.

Lin C, Franceschi S, Clifford GM

doi: 10.1016/

Viral Infections, Non-HIV

Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus

Vaccine.

Mok CC, Ho LY, To CH

doi: 10.1016/j.vaccine.2018.04.056.

Viral Infections, Non-HIV

Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

Viral Infections, Non-HIV

Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study

Clin Infect Dis.

Verdoodt F, Dehlendorff C, Kjaer SK

doi: 10.1093/cid/ciz239.

Viral Infections, Non-HIV

Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial

JAMA Pediatr.

Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O'Leary ST

doi: 10.1001/jamapediatrics.

Viral Infections, Non-HIV

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx

Vaccine.

Hales C, Jochems SP, Robinson R, Solórzano C, Carniel B, Pojar S, Reiné J, German EL, Nikolaou E, Mitsi E, Hyder-Wright AD, Hill H, Adler H, Connor V, Zaidi S, Lowe C, Fan X, Wang D, Gordon SB, Rylance J, Ferreira DM

doi: 10.1016/j.vaccine.2020.01.070.

Viral Infections, Non-HIV

Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis

Vaccine

Closson K, Karim ME, Sadarangani M, Naus M, Ogilvie GS, Donken R

doi: 10.1016/j.vaccine.2020.10.033

Related content

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis

Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus

Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review

Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study

Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx

Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial